Systemic lupus erythematosus following HPV immunization or infection?
about
Safety of human papillomavirus vaccines: a reviewSafety of human papillomavirus vaccines: a review.Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database.Lupus pathobiology based on genomics.A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events.EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndromeShould we target patients with autoimmune diseases for human papillomavirus vaccine uptake?Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum.Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.Human papillomavirus vaccine uptake among individuals with systemic inflammatory diseases.Refractory Genital HPV Infection and Adult-Onset Still Disease: A Case Report and Literature ReviewThe impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus.Vaccination and inflammatory arthritis: overview of current vaccines and recommended uses in rheumatology.Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus.Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role.Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases.Vaccination of patients with autoimmune inflammatory rheumatic diseases.The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases.Adjuvants- and vaccines-induced autoimmunity: animal models.Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome) - An update.Gastrointestinal system involvement in systemic lupus erythematosus.Current status and future prospects for human papillomavirus vaccines.HPV and systemic lupus erythematosus: a mosaic of potential crossreactions.A sudden onset of a pseudo-neurological syndrome after HPV-16/18 AS04-adjuvated vaccine: might it be an autoimmune/inflammatory syndrome induced by adjuvants (ASIA) presenting as a somatoform disorder?Human papillomavirus vaccine and systemic lupus erythematosus.Letter to the editor - HPV vaccine and autoimmunity Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study.Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.Quadrivalent human papillomavirus vaccination in girls and the risk of autoimmune disorders: the Ontario Grade 8 HPV Vaccine Cohort Study.Discrepancies in the evaluation of the safety of the human papillomavirus vaccine.
P2860
Q28082119-66D24E1E-4166-4359-A049-56FBC00A9A46Q33162724-BA42A62D-D9F9-4CB2-A0E4-2293E8864032Q33167424-43A147BD-21C4-43DD-8E54-7652EB6F0D1AQ33364409-13857CB6-D46F-40D9-81B7-AA85BEF7D1BCQ33419464-9775AEA1-9B18-4853-AB61-8ED06862C96FQ33731711-97C6D342-6713-4C61-BBC6-B8170E5FE2CEQ33905320-67D76E51-F9C8-44B0-B8F5-F2A94B574BCEQ34337165-3499A7E7-E777-49DE-BE63-FAA123229B0AQ34677865-A655D01D-0D5C-49EB-B5F7-D4B6261ECD0CQ35100677-E01101CA-5501-4DDA-BBFA-F30659C2489BQ36822297-BCBA2C21-A763-4151-943F-96D3E6D481A0Q37342515-D6ACEA5C-DE8D-405F-9FA4-7E6ABA36F090Q38103509-85C95E5B-A900-4C12-8A7F-4A5FEEBF14AEQ38182646-DBAD34C2-E170-4591-9E00-3CE44E41A523Q38225438-A5786262-0F6E-4463-A0BF-347466AD1E9DQ38266287-5C9211AB-33FA-4F40-A29F-D92FFEC43BC4Q38285275-F16842AD-316E-4E6A-8D18-806089A6F6DAQ38555725-2962B658-4BB0-4B8C-964F-0F599949FC34Q38841755-58D8678F-2C41-4EA8-AE20-50E99CF4C068Q39069734-2A4A4F43-9314-41AF-A838-A0D5D52A33F5Q39317590-943E9F09-00BE-462D-B618-9AF83C104247Q40056541-F79411FE-35A4-4D4E-A76A-C82C96D98D39Q40362384-0837CEFC-A6E0-45F5-9CBA-FE1172D7C4C7Q41666889-ECF39C9C-4A81-46A0-9A98-E9C3B0543D75Q45841999-E2BE847F-A0FA-4BBB-8C88-4EBD3E3352E3Q53814320-B173B426-2426-4E4A-BA9D-BC852F8A2A7FQ54262416-77408C47-F05C-41A9-8BCD-5948E880E315Q55223964-47BDCECC-422F-4480-8419-C9F9CC31E91AQ55314094-3D7CB679-C171-4E3C-A536-6019A175BA9A
P2860
Systemic lupus erythematosus following HPV immunization or infection?
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Systemic lupus erythematosus following HPV immunization or infection?
@ast
Systemic lupus erythematosus following HPV immunization or infection?
@en
type
label
Systemic lupus erythematosus following HPV immunization or infection?
@ast
Systemic lupus erythematosus following HPV immunization or infection?
@en
prefLabel
Systemic lupus erythematosus following HPV immunization or infection?
@ast
Systemic lupus erythematosus following HPV immunization or infection?
@en
P2093
P2860
P356
P1433
P1476
Systemic lupus erythematosus following HPV immunization or infection?
@en
P2093
H F Soldevilla
S F R Briones
S V Navarra
P2860
P304
P356
10.1177/0961203311429556
P577
2012-02-01T00:00:00Z